Anheuser-Busch InBev (BUD), the world's largest brewer, released its first quarter 2026 results on May 5, 2026. From what I see, these numbers offer valuable insights into global beer demand, especially as consumers shift toward premium and no-alcohol products. This report matters for investors because BUD continues to navigate U.S. market challenges stemming from prior brand issues, while leveraging megabrands like Corona and Stella Artois in emerging markets. Recent quarters have demonstrated resilience with consistent beats, though volume pressures in mature markets and currency volatility remain ongoing tests. The strong Q1 performance reinforces the company's execution on its premiumization strategy in a competitive landscape marked by inflation and regulatory hurdles.
For Q1 2026 (January-March), Anheuser-Busch InBev (BUD) posted revenue of $15.267 billion, reflecting a 5.8% organic increase (12.0% reported) from $13.628 billion in Q1 2025. This topped consensus estimates of about $14.7 billion. Revenue per hectoliter (hl) rose 4.5%, propelled by megabrands (up 8.2%), no-alcohol beer (up 27%), and Beyond Beer (up 37%). Total volumes grew 0.8% to 136.4 million hl, with beer volumes up 1.2% to 118.5 million hl—beating expectations of a decline.
Normalized EBITDA climbed 5.3% to $5.437 billion from $4.855 billion, exceeding consensus growth of 2.6%, although the margin dipped 15 basis points to 35.6%. Underlying profit reached $1.923 billion, up from $1.606 billion. Underlying EPS surged 20.8% to a Q1 record $0.97 (8.8% constant currency) from $0.81, above forecasts near $0.91. Reported profit attributable to equity holders was $2.563 billion versus $2.148 billion.
I also checked this using Tickeron’s AI Screener to see how BUD stacks up against peers on key metrics like revenue growth and margins.
In my own research, I rely on Tickeron’s AI Screener, an AI-powered tool for stock and ETF discovery. It lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. With customizable options like industry, market cap, technical indicators, price patterns, and performance metrics, scanning thousands of assets becomes far more efficient than manual methods. This helps pinpoint trade ideas, trending stocks, breakout candidates, and hidden opportunities. I find it enhances my strategy—worth exploring if you're looking to streamline your screening process.
As of early trading on May 5, 2026, after the pre-market earnings release, BUD shares showed a mixed initial reaction amid broader market conditions. The stock had closed at $73.91 on May 4, down 2.18%, with pre-market indications varying. Investors seem positive on the earnings beat and volume growth, but cautious about margin pressure and non-beer volume declines. Sentiment centers on premium brand momentum offsetting U.S. softness, and analysts are likely to emphasize the reaffirmed outlook. I'm watching this closely as the day unfolds.
Anheuser-Busch InBev (BUD) reaffirmed its FY 2026 guidance, projecting normalized EBITDA growth of 4-8%, aligned with medium-term targets. In my view, this signals confidence in megabrand execution and category leadership despite headwinds. Key details include quarterly net finance costs of $190-220 million, average gross debt coupon around 4%, normalized effective tax rate of 26-28%, and net capital expenditure of $3.5-4.0 billion. The company has completed $1.4 billion of a $6 billion share buyback program as of May 1.
One thing that stands out is the need to monitor megabrands like Corona (up 16% outside home market) and innovations in no-alcohol and Beyond Beer for sustained revenue per hl growth. Beer volume trends in high-growth markets like Mexico and Brazil, versus declines in non-beer, will be critical. Upcoming catalysts include major sporting events like the Milano Cortina Winter Olympics activation and broader 2026 celebrations to boost demand.
Keep an eye on margin dynamics amid cost inflation, currency impacts (positive in Q1), and BEES platform expansion (GMV up 15% to $14.6 billion). Progress on debt reduction (net debt to EBITDA at 2.87x end-2025) and free cash flow generation remains essential for shareholder returns.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The Moving Average Convergence Divergence (MACD) for BUD turned positive on April 30, 2026. Looking at past instances where BUD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 05, 2026. You may want to consider a long position or call options on BUD as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
BUD moved above its 50-day moving average on April 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BUD crossed bullishly above the 50-day moving average on April 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 236 cases where BUD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BUD broke above its upper Bollinger Band on May 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.830) is normal, around the industry mean (2.018). P/E Ratio (22.856) is within average values for comparable stocks, (23.645). Projected Growth (PEG Ratio) (1.960) is also within normal values, averaging (2.890). BUD has a moderately low Dividend Yield (0.016) as compared to the industry average of (0.035). BUD's P/S Ratio (2.680) is slightly higher than the industry average of (1.396).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BUD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages
Industry FoodMeatFishDairy